Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia. | Hemasphere | 2020 | 33196011 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Detects Novel Prognostic Subgroups of Breast Cancer. | Front Genet | 2020 | 33193681 | PubTator, text mining | PubMed |
| Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis. | Front Immunol | 2020 | 33193293 | PubTator, text mining | PubMed |
| Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database. | Int J Med Sci | 2020 | 33173439 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| Development of Therapeutic Vaccines for Ovarian Cancer. | Vaccines (Basel) | 2020 | 33167428 | PubTator, text mining | PubMed |
| Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment. | Bioengineered | 2020 | 33164640 | PubTator, text mining | PubMed |
| Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers. | Cell Rep Med | 2020 | 33163982 | PubTator, text mining | PubMed |
| Defining the clinical genomic landscape for real-world precision oncology. | Genomics | 2020 | 33144218 | PubTator, text mining | PubMed |
| Live long and active: Polypeptide-mediated assembly of antibody variable fragments. | Adv Drug Deliv Rev | 2020 | 33129938 | PubTator, text mining | PubMed |
| Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools. | Cancers (Basel) | 2020 | 33126572 | PubTator, text mining | PubMed |
| Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL. | Onco Targets Ther | 2020 | 33122918 | PubTator, text mining | PubMed |
| Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease. | Pharmgenomics Pers Med | 2020 | 33116761 | PubTator, text mining | PubMed |
| Role of Platelet Cytokines in Dengue Virus Infection. | Front Cell Infect Microbiol | 2020 | 33102253 | PubTator, text mining | PubMed |
| Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy. | Cancers (Basel) | 2020 | 33092116 | PubTator, text mining | PubMed |
| Malignant Melanoma: A Double Malignancy or Second Malignant Neoplasm in a Patient of Acute Lymphoblastic Leukemia Following Therapy with a Composite Karyotype. | Int J Appl Basic Med Res | 2020 | 33088748 | PubTator, text mining | PubMed |
| Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC). | Antibodies (Basel) | 2020 | 33081115 | PubTator, text mining | PubMed |
| Assessment of Fibrinogen Macromolecules Interaction with Red Blood Cells Membrane by Means of Laser Aggregometry, Flow Cytometry, and Optical Tweezers Combined with Microfluidics. | Biomolecules | 2020 | 33076409 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis. | Front Cell Dev Biol | 2020 | 33072752 | PubTator, text mining | PubMed |
| Mass Cytometry Analysis of the NK Cell Receptor-Ligand Repertoire Reveals Unique Differences between Dengue-Infected Children and Adults. | Immunohorizons | 2020 | 33067399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=54